Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Ikena Oncology (IKNA)

Ikena Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IKNA
DateTimeSourceHeadlineSymbolCompany
10/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
28/05/202421:42GlobeNewswire Inc.UPDATE – Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
28/05/202421:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
28/05/202421:15GlobeNewswire Inc.Ikena Oncology Announces Strategic UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202421:45GlobeNewswire Inc.Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
13/05/202421:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
10/04/202413:00GlobeNewswire Inc.Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IKNAIkena Oncology Inc
12/03/202412:00GlobeNewswire Inc.Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
05/03/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
05/03/202421:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
27/02/202413:00GlobeNewswire Inc.Ikena Oncology to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:IKNAIkena Oncology Inc
21/02/202421:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
21/02/202421:15GlobeNewswire Inc.Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical OfficerNASDAQ:IKNAIkena Oncology Inc
02/02/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
02/02/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IKNAIkena Oncology Inc
18/01/202421:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
18/01/202421:05GlobeNewswire Inc.Ikena Oncology Outlines Key Priorities and Provides Corporate UpdatesNASDAQ:IKNAIkena Oncology Inc
09/11/202312:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IKNAIkena Oncology Inc
09/11/202312:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
09/11/202312:00GlobeNewswire Inc.Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial ResultsNASDAQ:IKNAIkena Oncology Inc
07/11/202313:00GlobeNewswire Inc.Ikena Oncology to Present at Multiple November 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
11/10/202322:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IKNAIkena Oncology Inc
25/09/202321:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IKNAIkena Oncology Inc
15/09/202321:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IKNAIkena Oncology Inc
12/09/202321:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IKNAIkena Oncology Inc
11/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IKNAIkena Oncology Inc
05/09/202313:00GlobeNewswire Inc.Ikena Oncology to Participate in September 2023 Investor ConferencesNASDAQ:IKNAIkena Oncology Inc
18/08/202321:03Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IKNAIkena Oncology Inc
18/08/202321:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IKNAIkena Oncology Inc
10/08/202313:00GlobeNewswire Inc.Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:IKNAIkena Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:IKNA